GENEVA, March 10 -- SIGNPATH PHARMA INC. (9710 Ruskin CircleSandy, UT 84092) filed a patent application (PCT/US2024/041253) for "CARDIOPROTECTIVE LIPIDS AND METHODS OF USE" on Aug 07, 2024. With publication no. WO/2025/049064, the details related to the patent application was published on Mar 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LEVY, Daniel, Emil (37 Lakewood CircleSan Mateo, CA 94402)
Abstract:
The present invention includes a method of reducing or eliminating a cardiotoxic or cardiopathic effect of one or more active agents comprising: administering to a subject in need ...